Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Inovio Pharmaceuticals Inc INO

Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines pipeline include INO-3107 for HPV-related recurrent respiratory papillomatosis (RRP); INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, or OPSCC; VGX-3100 for the treatment of Anal or Perianal HSIL; INO-5401 for the treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Treatment of Glioblastoma Multiforme (GBM). Its lead candidate is INO-3107 for the treatment of RRP, a rare and debilitating disease of the respiratory tract caused by HPV infection. Its DNA medicines platform consists of DNA plasmids and its CELLECTRA devices, which are used to deliver the DNA plasmids into the cell. Its CELLECTRA device portfolio consists of two models.


NDAQ:INO - Post by User

Bullboard Posts
Post by Miner1967on May 29, 2016 2:46pm
263 Views
Post# 24914231

I rec'd INO & 4X, check now AKAO

I rec'd INO & 4X, check now AKAO

(AKAO stands for Achaogen inc, listed in NASDAQ.)

https://www.stockhouse.com/companies/bullboard/ino/inovio-pharmaceuticals-inc?postid=22003275

Above it's one of my posts in INO back in 2013. That year INO quadrupled...

After 3 years I have found a U.S. listed bio stock with the same potential: AKAO.

-It trades at its cash.

-It has a market cap of 50 million only, while institutional and state institutions have invest in the company more than 300 million.

-Its pps has dropped due to bio sector collapse, not because of any failure: All its clinical results are quite positive.

-A few days ago the "Nightmare" e.coli family Bacteria appeared in U.S. (Pennsylvania). After that, recearchers found it to pork meat also.

https://www.washingtonpost.com/news/to-your-health/wp/2016/05/26/the-superbug-that-doctors-have-been-dreading-just-reached-the-u-s/

Achaogen is the only company have a drug (Plazomicin) in Phase III clinical trials, to fight this bacteria. The results at Phase II have been characterized from independent recearchers as "excellent".

Check also the chart and the technicals of AKAO below:

https://charts.stocktwits.com/production/original_55731914.?1464441631

Well, that's all folks! :)) Few will read and fewer will spend a few minutes to confirm.
To those, do you DD and good luck. Personally I will try to buy in Tuesday until 3.35.

Bullboard Posts